文献速递其他结缔组织病

整合外显子组测序与机器学习识别MICB及干扰素通路基因参与系统性硬化症风险

Integrative exome sequencing and machine learning identify MICB and interferon pathway genes as contributors to SSc risk.
PubMed 文献 · Ann Rheum Dis · 2025-06-13

该研究整合外显子组测序、进化动作-机器学习框架、单细胞RNA测序和表达数量性状位点分析,在2559例系统性硬化症(SSc)病例和893例对照中开展GWAS,并在9846例病例和18333例对照中重复验证,识别出MICB新风险位点(rs2516497,P=3.66×10-13),并提示284个基因富集于干扰素信号通路。

要点

  • 识别并重复验证MICB新风险位点rs2516497(P=3.66×10-13)。
  • EAML框架优先选出284个富集于干扰素信号的基因。
  • scRNA-seq将MICB和NOTCH4定位至成纤维细胞和内皮细胞。

核心结论

  • 该整合基因组研究识别出SSc新风险位点和机制通路,突出MICB、NOTCH4及干扰素相关基因。

研究设计与样本

  • 在2559例SSc病例和893例白人 ancestry 对照中开展GWAS,并在9846例欧洲 ancestry 病例和18333例对照中重复验证。
  • 整合外显子组测序与进化动作-机器学习框架优先选出高影响错义变异预测疾病的基因。
  • 分析SSc和对照皮肤活检的公开单细胞RNA测序数据以定位基因在不同细胞类型的表达。
  • 使用全血表达数量性状位点数据识别风险变异的调控效应。

主要发现

  • 识别出MICB新SSc风险位点rs2516497(P=3.66×10-13)并得到重复验证。
  • EAML突出284个富集于干扰素信号的基因。
  • scRNA-seq将MICB和NOTCH4定位至成纤维细胞和内皮细胞,HLA II类基因富集于巨噬细胞和成纤维细胞。
  • eQTL分析证实MICB、NOTCH4及其他优先基因的调控效应,将SSc相关变异与转录失调联系起来。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic sclerosis (SSc) is a complex autoimmune disease with both known and unidentified genetic contributors. While genome-wide association studies (GWAS) have implicated multiple loci, many reside in noncoding regions. We aimed to identify novel protein-coding variants and pathogenic pathways using exome sequencing (ES) integrated with an Evolutionary Action-Machine Learning (EAML) framework, single-cell RNA sequencing (scRNA-seq), and expression quantitative trait locus (eQTL) analysis. METHODS: GWAS was conducted in 2,559 SSc cases and 893 controls of Caucasian ancestry, with replication in 9,846 cases and 18,333 controls of European ancestry. EAML prioritized genes with high-impact missense variants predictive of disease. Public scRNA-seq data from SSc and control skin biopsies were analyzed to localize gene expression across cell types. Whole blood eQTL data were used to identify regulatory effects of risk variants. RESULTS: A novel SSc risk locus at MICB (rs2516497, P = 3.66 × 10-13) was identified and replicated. EAML highlighted 284 genes enriched in interferon signaling. scRNA-seq localized MICB and NOTCH4 to fibroblasts and endothelial cells, while HLA class II genes were enriched in macrophages and fibroblasts. eQTL analysis confirmed regulatory effects at MICB, NOTCH4, and other prioritized genes, linking SSc-associated variants to transcriptional dysregulation. CONCLUSIONS: This integrative genomic study identifies novel risk loci and mechanistic pathways in SSc, highlighting MICB, NOTCH4, and interferon-related genes. The findings provide insight into the cellular and regulatory architecture of SSc and support the utility of combining ES, machine learning, scRNA-seq, and eQTL data in complex disease genetics.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Ketkar S, Dai H, Burrage L, et al. Integrative exome sequencing and machine learning identify MICB and interferon pathway genes as contributors to SSc risk. Ann Rheum Dis. 2025. PMID: 40514331. doi:10.1016/j.ard.2025.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。